Oncology

Immune checkpoint blockade and gene therapy more effective together than alone in brain cancer.

Oncology pharmacists play an important role in the delivery of care to patients living with cancer.

Top news of the week in oncology and cancer drug development.

LJ is a 75-year-old patient with advanced breast cancer. She also has a medical history of hypertension and dementia. LJ decided to stop chemotherapy 2 months ago due to severe nausea, vomiting, and diarrhea.

New at-risk group for skin cancer identified.

Americans living in rural areas more likely to die from top 5 causes of death, including cancer.

The novel tool will be integrated into the National Cancer Institute’s current risk assessment tool.

A $1 million competition announced with a goal of reducing lung cancer deaths by 20%.

Higher intake of grilled, barbecued, and smoked meats increases mortality risk among cancer survivors.

Investigational treatment for scleroderma autoimmune disease shows high efficacy in melanoma patients.

Systemic chemotherapy combined with immunotherapy negatively impacts the immune system compared with local chemotherapy plus immunotherapy.

Top news of the day from across the healthcare landscape.

In 2015, there were 17.5 million cases of cancer worldwide and 8.7 million cancer-related deaths.

Atezolizumab being examined as first-line treatment for individuals ineligible for cisplatin chemotherapy.

Combination approach better targets breast cancer tumors with PIK3CA gene mutations.

Top news of the week in oncology and cancer drug development.

Nonsteroidal anti-inflammatory drugs effective in preventing advanced neoplasia recurrence.

Combination therapy may help combat treatment resistance in cancer patients.

Top news of the day from across the health care landscape.

ASN003 is a drug that targets cancers driven by BRAF and PI3K.

ASN003 demonstrated potent action against tumor growth.

Device helps surgeons distinguish between cancerous and non-cancerous tissues.

Treatment with antihypertensive drugs was seen to lower cancer-related proteins.

Top news of the day from across the health care landscape.

Aspirin may serve as a preventive measure for pancreatic cancer development.

The FDA has granted priority review for the supplemental new drug application (sNDA) from Bayer for Stivarga, also known as regorafenib.

Certain hypertension drugs block breast and pancreatic cancer invasion.

Cancer accounts for more years of life lost than any other cause of death.